Skip to content

Clinical trials

Terminated Phase 1 Lymphoma, T-Cell, Peripheral trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Phase: Phase 1 Status: Terminated Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20092
20101
20122
20131
20151
20161
20171
20191
20202
20221
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Barbara Ann Karmanos Cancer Institute2
National Cancer Institute (NCI)2
Pfizer2
Seagen, a wholly owned subsidiary of Pfizer2
Taiho Oncology, Inc.2
Aptevo Therapeutics1
Axter Therapeutics (Beijing) Co., Ltd1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
City of Hope Medical Center1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral21
Lymphoma, Large B-Cell, Diffuse13
Leukemia, Lymphocytic, Chronic, B-Cell11
Lymphoma, Large-Cell, Anaplastic11
Lymphoma, Non-Hodgkin11
Lymphoma, T-Cell, Cutaneous11
Hodgkin Disease9
Immunoblastic Lymphadenopathy9
Burkitt Lymphoma8
Lymphoma, Extranodal NK-T-Cell8

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.